← All trials
MetabolicActive

Multinational Biological Age Clock Validation Study

The Consortium's flagship trial: validating a shared biological-age clock across seven countries and diverse ancestries: one protocol, one budget, one dataset.

Sponsor

Karolinska Longevity Institute (Stockholm, Sweden)

Lead investigator

Elena Kovač, MD, PhD

Metabolic health researcher focused on early pharmacological intervention in pre-diabetic ageing populations.

Trial sites

  • Karolinska Longevity Institute (Stockholm, Sweden)
  • Singapore Centre for Healthy Longevity (Singapore, Singapore)
  • Mayo Clinic Center for Regenerative Medicine (Rochester, United States)
  • Max Planck Institute for Biology of Ageing (Cologne, Germany)
  • University of São Paulo, Aging Biology Unit (São Paulo, Brazil)
  • Kyoto University Institute for Frontier Life Sciences (Kyoto, Japan)
  • University of Cape Town, Longevity Research Group (Cape Town, South Africa)